Beauty Health (NASDAQ:SKIN) Price Target Raised to $1.75

Beauty Health (NASDAQ:SKIN) had its target price upped by Canaccord Genuity Group from $1.25 to $1.75 in a research report sent to investors on Wednesday,Benzinga reports. They currently have a hold rating on the stock.

Several other research analysts have also recently commented on the company. Stifel Nicolaus lowered their target price on Beauty Health from $4.00 to $2.00 and set a “hold” rating for the company in a research note on Friday, July 26th. Piper Sandler reaffirmed an “underweight” rating and set a $1.00 price objective (down from $1.50) on shares of Beauty Health in a research report on Friday, August 9th. Three analysts have rated the stock with a sell rating, seven have given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $2.54.

Beauty Health Trading Up 8.8 %

SKIN opened at $1.85 on Wednesday. Beauty Health has a 12 month low of $0.91 and a 12 month high of $5.17. The stock has a market capitalization of $229.44 million, a price-to-earnings ratio of -4.40 and a beta of 0.90. The company has a debt-to-equity ratio of 7.96, a current ratio of 6.49 and a quick ratio of 5.47. The business has a fifty day moving average price of $1.57 and a 200 day moving average price of $1.89.

Institutional Trading of Beauty Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. SG Americas Securities LLC acquired a new stake in shares of Beauty Health in the 3rd quarter worth approximately $37,000. Caprock Group LLC acquired a new stake in shares of Beauty Health in the 2nd quarter worth approximately $38,000. Sanctuary Advisors LLC acquired a new stake in shares of Beauty Health in the 2nd quarter worth approximately $47,000. SageView Advisory Group LLC acquired a new stake in Beauty Health during the 1st quarter valued at $60,000. Finally, Susquehanna Fundamental Investments LLC acquired a new stake in Beauty Health during the 2nd quarter valued at $105,000. 93.26% of the stock is owned by hedge funds and other institutional investors.

About Beauty Health

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.